Showing your ID: Intrinsic disorder as an ID for recognition, regulation and cell signaling

Journal of Molecular Recognition

Volumn 18, Issue 5, 2005, Pages 343-384

  Uversky, Vladimir N ^a,b,c   Oldfield, Christopher J ^a,d   Dunker, A Keith ^a,b  

^a Molecular Kinetics Inc   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSTITUTE FOR BIOLOGICAL INSTRUMENTATION   (Russian Federation)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Highly flexible; Intrinsically unstructured; Molecular recognition; Molten globule; Natively unfolded; Random coil; Rheomorphic

Indexed keywords

ANTIGEN; CHAPERONE; NUCLEIC ACID; PROTEIN;

ANIMAL; CHEMISTRY; HUMAN; METABOLISM; PROTEIN CONFORMATION; PROTEIN FOLDING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS; HUMANS; MOLECULAR CHAPERONES; NUCLEIC ACIDS; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEINS; SIGNAL TRANSDUCTION;

MEASLES VIRUS;

EID: 25144472591     PISSN: 09523499     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmr.747     Document Type: Review

References (453)

1. Abello J, Kaiserlian D, Cuber JC, Revillard JP, Chayvialle JA. 1991. Characterization of calcitonin gene-related peptide receptors and adenylate cyclase response in the murine macrophage cell line P388 D1. Neuropeptides 19: 43-49.
2. Acharya R, Fry E, Stuart D, Fox G, Rowlands D, Brown F. 1989. The 3-dimensional structure of foot-and-mouth-disease virus at 2.9-a resolution. Nature 337: 709-716.
3. Adler AJ, Greenfield NJ, Fasman GD. 1973. Circular dichroism and optical rotatory dispersion of proteins and polypeptides. Meth. Enzymol. 27: 675-735.
4. Afasizheva I, Dolgikh DA, Kirpichnikov MP. 1999. Immunogenic properties of albeferon - biologically active artificial protein. Mol. Biol. (Mosk.) 33: 679-683.
5. Agrawal RK, Penczek P, Grassucci RA, Frank J. 1998. Visualization of elongation factor G on the Escherichia coli 70S ribosome: the mechanism of translocation. Proc. Natl Acad. Sci. USA 95: 6134-6138.
6. Agrawal RK, Heagle AB, Penczek P, Grassucci RA, Frank J. 1999. EF-G-dependent GTP hydrolysis induces translocation accompanied by large conformational changes in the 70S ribosome. Nat. Struct. Biol. 6: 643-657.
7. Allain FH, Gubser CC, Howe PW, Nagai K, Neuhaus D, Varani G. 1996. Specificity of ribonucleoprotein interaction determined by RNA folding during complex formulation. Nature 380: 646-650.
8. Allain FH, Yen YM, Masse JE, Schultze P, Dieckmann T, Johnson RC, Feigon J. 1999. Solution structure of the HMG protein NHP6A and its interaction with DNA reveals the structural determinants for non-sequence-specific binding. Embo J. 18: 2563-2579.
9. Allan JS, Coligan JE, Barin F, McLane MF, Sodroski JG, Rosen CA, Haseltine WA, Lee TH, Essex M. 1985. Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science 228: 1091-1094.
10. Antz C, Geyer M, Fakler B, Schott MK, Guy HR, Frank R, Ruppersberg JP, Kalbitzer HR. 1997. NMR structure of inactivation gates from mammalian voltage-dependent potassium channels. Nature 385: 272-275.
11. Aprelikova ON, Fang BS, Meissner EG, Cotter S, Campbell M, Kuthiala A, Bessho M, Jensen RA, Liu ET. 1999. BRCA1-associated growth arrest is RB-dependent. Proc. Natl Acad. Sci. USA 96: 11866-11871.
12. Armstrong CM, Bezanilla F. 1977. Inactivation of the sodium channel. II. Gating current experiments. J. Gen. Physiol. 70: 567-590.
13. Atassi MZ, Smith JA. 1978. A proposal for the nomenclature of antigenic sites in peptides and proteins. Immunochemistry 15: 609-610.
14. Bailey RW, Dunker AK, Brown CJ, Garner EC, Griswold MD. 2001. Clusterin, a binding protein with a molten globule-like region. Biochemistry 40: 11828-11840.
15. Balbach JJ, Yang J, Weliky DP, Steinbach PJ, Tugarinov V, Anglister J, Tycko R. 2000. Probing hydrogen bonds in the antibody-bound HIV-1 gp120 V3 loop by solid state NMR REDOR measurements. J. Biomol. NMR 16: 313-327.
16. Ban N, Nissen P, Hansen J, Moore PB, Steitz TA. 2000. The complete atomic structure of the large ribosomal subunit at 2.4 A resolution. Science 289: 905-920.
17. Bankamp B, Horikami SM, Thompson PD, Huber M, Billeter M, Moyer SA. 1996. Domains of the measles virus N protein required for binding to P protein and self-assembly. Virology 216: 272-277.
18. Barabasi AL, Albert R. 1999. Emergence of scaling in random networks. Science 286: 509-512.
19. Barabasi AL, Bonabeau E. 2003. Scale-free networks. Sci. Am. 288: 60-69.
20. Barabasi AL, Oltvai ZN. 2004. Network biology: understanding the cell's functional organization. Nat. Rev. Genet. 5: 101-113.
21. Barnett PV, Ouldridge EJ, Rowlands DJ, Brown F, Parry NR. 1989. Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites. J. Gen. Virol. 70(Pt 6): 1483-1491.
22. Bastos M, Pease JH, Wemmer DE, Murphy KP, Connelly PR. 2001. Thermodynamics of the helix-coil transition: Binding of S15 and a hybrid sequence, disulfide stabilized peptide to the S-protein. Proteins 42: 523-530.
23. Bax B, Carter PS, Lewis C, Guy AR, Bridges A, Tanner R, Pettman G, Mannix C, Culbert AA, Brown MJ, Smith DG, Reith AD. 2001. The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation. Structure (Camb.) 9: 1143-1152.
24. Behrens J, Jerchow BA, Wurtele M, Grimm J, Asbrand C, Wirtz R, Kuhl M, Wedlich D, Birchmeier W. 1998. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280: 596-599.
25. Bell CE, Lewis M. 2001. The Lac repressor: a second generation of structural and functional studies. Curr. Opin. Struct. Biol. 11: 19-25.
26. 2+- and voltage-activated potassium channels. J. Biol. Chem. 276: 42116-42121.
27. Berger C, Weber-Bornhauser S, Eggenberger J, Hanes J, Pluckthun A, Bosshard HR. 1999. Antigen recognition by conformational selection. FEBS Lett. 450: 149-153.
28. Berger EA. 1997. HIV entry and tropism: the chemokine receptor connection. AIDS 11(suppl. A): S3-S16.
29. Berzofsky JA. 1985. Intrinsic and extrinsic factors in protein antigenic structure. Science 229: 932-940.
30. Bezanilla F, Armstrong CM. 1977. Inactivation of the sodium channel. I. Sodium current experiments. J. Gen. Physiol. 70: 549-566.
31. Bhattacharyya J, Das KP. 1999. Molecular chaperone-like properties of an unfolded protein, alpha(s)-casein. J. Biol. Chem. 274: 15505-15509.
32. Bittle JL, Houghten RA, Alexander H, Shinnick TM, Sutcliffe JG, Lerner RA, Rowlands DJ, Brown F. 1982. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298: 30-33.
33. Bosshard HR. 2001. Molecular recognition by induced fit: how fit is the concept? News Physiol. Sci. 16: 171-173.
34. Bothner B, Lewis WS, DiGiammarino EL, Weber JD, Bothner SJ, Kriwacki RW. 2001. Defining the molecular basis of Arf and Hdm2 interactions. J. Mol. Biol. 314: 263-277.
35. Bourhis JM, Johansson K, Receveur-Brechot V, Oldfield CJ, Dunker KA, Canard B, Longhi S. 2004. The C-terminal domain of measles virus nucleoprotein belongs to the class of intrinsically disordered proteins that fold upon binding to their physiological partner. Virus Res. 99: 157-167.
36. Bouvier M. 2003. Accessory proteins and the assembly of human class I MHC molecules: a molecular and structural perspective. Mol. Immunol. 39: 697-706.
37. Bouvier M, Stafford WF. 2000. Probing the three-dimensional structure of human calreticulin. Biochemistry 39: 14950-14959.
38. Bracken C, Carr PA, Cavanagh J, Palmer AG 3rd. 1999. Temperature dependence of intramolecular dynamics of the basic leucine zipper of GCN4: implications for the entropy of association with DNA. J. Mol. Biol. 285: 2133-2146.
39. Bracken C, Iakoucheva LM, Romero PR, Dunker AK. 2004. Combining prediction, computation and experiment for the characterization of protein disorder. Curr. Opin. Struct. Biol. 14: 570-576.
40. Brown RK. 1962. Studies on the antigenic structure of ribonuclease. III. Inhibition by peptides of antibody to performic acid-oxidized ribonuclease. J. Biol. Chem. 237: 1162-1167.
41. Bryant JE, Lecomte JT, Lee AL, Young GB, Pielak GJ. 2005. Protein Dynamics in Living Cells. Biochemistry 44: 9275-9279.
42. Brzovic PS, Rajagopal P, Hoyt DW, King MC, Klevit RE. 2001. Structure of a BRCA1-BARD1 heterodimeric RING-RING complex. Nat. Struct. Biol. 8: 833-837.
43. Brzovic PS, Keeffe JR, Nishikawa H, Miyamoto K, Fox D 3rd, Fukuda M, Ohta T, Klevit R. 2003. Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex. Proc. Natl Acad. Sci. USA 100: 5646-5651.
44. Buchholz CJ, Retzler C, Homann HE, Neubert WJ. 1994. The carboxy-terminal domain of Sendai virus nucleocapsid protein is involved in complex formation between phosphoprotein and nucleocapsid-like particles. Virology 204: 770-776.
45. Bustin M. 2001. Revised nomenclature for high mobility group (HMG) chromosomal proteins. Trends Biochem. Sci. 26: 152-153.
46. Bustin M, Reeves R. 1996. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog. Nucl. Acid Res. Mol. Biol. 54: 35-100.
47. Callaghan AJ, Aurikko JP, Ilag LL, Gunter Grossmann J, Chandran V, Kuhnel K, Poljak L, Carpousis AJ, Robinson CV, Symmons MF, Luisi BF. 2004. Studies of the RNA degradosome-organizing domain of the Escherichia coli ribonuclease RNase E. J. Mol. Biol. 340: 965-979.
48. Cary PD, Moss T, Bradbury EM. 1978. High-resolution protonmagnetic- resonance studies of chromatin core particles. Eur. J. Biochem. 89: 475-482.
49. Casaregola S, Jacq A, Laoudj D, McGurk G, Margarson S, Tempete M, Norris V, Holland IB. 1992. Cloning and analysis of the entire Escherichia coli ams gene, ams is identical to hmp1 and encodes a 114kDa protein that migrates as a 180 kDa protein. J. Mol. Biol. 228: 30-40.
50. Chen J, Silver DP, Walpita D, Cantor SB, Gazdar AF, Tomlinson G, Couch FJ, Weber BL, Ashley T, Livingston DM, Scully R. 1998. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells. Mol. Cell 2: 317-328.
51. Chiappetta G, Avantaggiato V, Visconti R, Fedele M, Battista S, Trapasso F, Merciai BM, Fidanza V, Giancotti V, Santoro M, Simeone A, Fusco A. 1996. High level expression of the HMGI (Y) gene during embryonic development. Oncogene 13: 2439-2446.
52. Chilcott GS, Hughes KT. 1998. The type III secretion determinants of the flagellar anti-transcription factor, FlgM, extend from the amino-terminus into the anti-sigma28 domain. Mol. Microbiol. 30: 1029-1040.
53. Cho Y, Gorina S, Jeffrey PD, Pavletich NP. 1994. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265: 346-355.
54. Choo Y, Schwabe JW. 1998. All wrapped up. Nat. Struct. Biol. 5: 253-255.
55. Christian RB, Zuckermann RN, Kerr JM, Wang L, Malcolm BA. 1992. Simplified methods for construction, assessment and rapid screening of peptide libraries in bacteriophage. J. Mol. Biol. 227: 711-718.
56. Christodoulou J, Larsson G, Fucini P, Connell SR, Pertinhez TA, Hanson CL, Redfield C, Nierhaus KH, Robinson CV, Schleucher J, Dobson CM. 2004. Heteronuclear NMR investigations of dynamic regions of intact Escherichia coli ribosomes. Proc. Natl Acad. Sci. USA 101: 10949-10954.
57. Claverie-Martin F, Diaz-Torres MR, Yancey SD, Kushner SR. 1991. Analysis of the altered mRNA stability (ams) gene from Escherichia coli. Nucleotide sequence, transcriptional analysis, and homology of its product to MRP3, a mitochondrial ribosomal protein from Neurospora crassa. J. Biol. Chem. 266: 2843-2851.
58. Coeytaux K, Poupon A. 2005. Prediction of unfolded segments in a protein sequence based on amino acid composition. Bioinformatics 21: 1891-1900.
59. Cohen P. 1999. The Croonian Lecture 1998. Identification of a protein kinase cascade of major importance in insulin signal transduction. Phil. Trans. R. Soc. Lond. B Biol. Sci. 354: 485-495.
60. Cohen SN, McDowall KJ. 1997. RNase E: still a wonderfully mysterious enzyme. Mol. Microbiol. 23: 1099-1106.
61. Connolly ML. 1983. Solvent-accessible surfaces of proteins and nucleic acids. Science 221: 709-713.
62. Conte MR, Grune T, Ghuman J, Kelly G, Ladas A, Matthews S, Curry S. 2000. Structure of tandem RNA recognition motifs from polypyrimidine tract binding protein reveals novel features of the RRM fold. Embo J. 19: 3132-3141.
63. Cortez D, Wang Y, Qin J, Elledge SJ. 1999. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Science 286: 1162-1166.
64. Craig TA, Veenstra TD, Naylor S, Tomlinson AJ, Johnson KL, Macura S, Juranic N, Kumar R. 1997. Zinc binding properties of the DNA binding domain of the 1,25-dihydroxyvitamin D3 receptor. Biochemistry 36: 10482-10491.
65. Cristofari G, Gabus C, Ficheux D, Bona M, Le Grice SF, Darlix JL. 1999. Characterization of active reverse transcriptase and nucleoprotein complexes of the yeast retrotransposon Ty3 in vitro. J. Biol. Chem. 274: 36643-36648.
66. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. 1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789.
67. Crumpton MJ. 1966. Conformational changes in sperm-whale metmyoglobin due to combination with antibodies to apomyoglobin. Biochem. J. 100: 223-232.
68. Csermely P. 1997. Proteins, RNAs and chaperones in enzyme evolution: a folding perspective. Trends Biochem. Sci. 22: 147-149.
69. Csermely P. 1999. Chaperone-percolator model: a possible molecular mechanism of Anfinsen-cage-type chaperones. Bioessays 21: 959-965.
70. Curran J, Homann H, Buchholz C, Rochat S, Neubert W, Kolakofsky D. 1993. The hypervariable C-terminal tail of the Sendai paramyxovirus nucleocapsid protein is required for template function but not for RNA encapsidation. J. Virol. 67: 4358-4364.
71. Curry S, Fry E, Blakemore W, Abu-Ghazaleh R, Jackson T, King A, Lea S, Newman J, Rowlands D, Stuart D. 1996. Perturbations in the surface structure of A22 Iraq foot-and-mouth disease virus accompanying coupled changes in host cell specificity and antigenicity. Structure 4: 135-145.
72. Czurylo EA, Zborowski J, Dabrowska R. 1993. Interaction of caldesmon with phospholipids. Biochem. J. 291(Pt 2): 403-408.
73. Dajani R, Fraser E, Roe SM, Young N, Good V, Dale TC, Pearl LH. 2001. Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 105: 721-732.
74. Dajani R, Fraser E, Roe SM, Yeo M, Good VM, Thompson V, Dale TC, Pearl LH. 2003. Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex. Embo J. 22: 494-501.
75. Dames SA, Martinez-Yamout M, De Guzman RN, Dyson HJ, Wright PE. 2002. Structural basis for Hif-1 alpha/CBP recognition in the cellular hypoxic response. Proc. Natl Acad. Sci. USA 99: 5271-5276.
76. Daughdrill GW, Chadsey MS, Karlinsey JE, Hughes KT, Dahlquist FW. 1997. The C-terminal half of the anti-sigma factor, FlgM, becomes structured when bound to its target, sigma 28. Nat. Struct. Biol. 4: 285-291.
77. Daughdrill GW, Pielak GJ, Uversky VN, Cortese MS, Dunker AK. 2005. Natively disordered proteins. In Handbook of Protein Folding, Buchner J, Kiefhaber T (eds). Wiley-VCH: Weinheim; 271-353.
78. Davies DR, Cohen GH. 1996. Interactions of protein antigens with antibodies. Proc. Natl Acad. Sci. USA 93: 7-12.
79. Dedmon MM, Patel CN, Young GB, Pielak GJ. 2002. FlgM gains structure in living cells. Proc. Natl Acad. Sci. USA 499: 12681-12684.
80. Demchenko AP. 2001. Recognition between flexible protein molecules: induced and assisted folding. J. Mol. Recognit. 14: 42-61.
81. Dev KK, Hofele K, Barbieri S, Buchman VL, van der Putten H. 2003. Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease. Neuropharmacology 45: 14-44.
82. Dey D, Bochkariov DE, Jokhadze GG, Traut RR. 1998. Cross-linking of selected residues in the N- and C-terminal domains of Escherichia coli protein L7/L12 to other ribosomal proteins and the effect of elongation factor Tu. J. Biol. Chem. 273: 1670-1676.
83. DiGiammarino EL, Filippov I, Weber JD, Bothner B, Kriwacki RW. 2001. Solution structure of the p53 regulatory domain of the p19Arf tumor suppressor protein. Biochemistry 40: 2379-2386.
84. DiMarchi R, Brooke G, Gale C, Cracknell V, Doel T, Mowat N. 1986. Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science 232: 639-641.
85. Ding Y, Dale T. 2002. Wnt signal transduction: kinase cogs in a nano-machine? Trends Biochem. Sci. 27: 327-329.
86. DiNitto JP, Huber PW. 2003. Mutual induced fit binding of Xenopus ribosomal protein L5 to 5S rRNA. J. Mol. Biol. 330: 979-992.
87. Disney JE, Johnson KR, Magnuson NS, Sylvester SR, Reeves R. 1989. High-mobility group protein HMG-I localizes to G/Q- and C-bands of human and mouse chromosomes. J. Cell Biol. 109: 1975-1982.
88. Diwa AA, Jiang X, Schapira M, Belasco JG. 2002. Two distinct regions on the surface of an RNA-binding domain are crucial for RNase E function. Mol. Microbiol. 46: 959-969.
89. Dosztanyi Z, Csizmok V, Tompa P, Simon I. 2005. The pairwise energy content estimated from amino acid composition discriminates between folded and intrinsically unstructured proteins. J. Mol. Biol. 347: 827-839.
90. Dreyer T, Valler MJ, Kay J, Charlton P, Dunn BM. 1985. The selectivity of action of the aspartic-proteinase inhibitor IA3 from yeast (Saccharomyces cerevisiae). Biochem. J. 231: 777-779.
91. Dunker AK, Obradovic Z. 2001. The protein trinity - linking function and disorder. Nat. Biotechnol. 19: 805-806.
92. Dunker AK, Garner E, Guilliot S, Romero P, Albrecht K, Hart J, Obradovic Z, Kissinger C, Villafranca JE. 1998. Protein disorder and the evolution of molecular recognition: theory, predictions and observations. Pac. Symp. Biocomput. 473-484.
93. Dunker AK, Obradovic Z, Romero P, Garner EC, Brown CJ. 2000. Intrinsic protein disorder in complete genomes. Genome Inform. Ser. Workshop Genome Inform. 11: 161-171.
94. Dunker AK, Lawson JD, Brown CJ, Williams RM, Romero P, Oh JS, Oldfield CJ, Campen AM, Ratliff CM, Hipps KW, Ausio J, Nissen MS, Reeves R, Kang C, Kissinger CR, Bailey RW, Griswold MD, Chiu W, Garner EC, Obradovic Z. 2001. Intrinsically disordered protein. J. Mol. Graph. Model 19: 26-59.
95. Dunker AK, Brown CJ, Lawson JD, Iakoucheva LM, Obradovic Z. 2002a. Intrinsic disorder and protein function. Biochemistry 41: 6573-6582.
96. Dunker AK, Brown CJ, Obradovic Z. 2002b. Identification and functions of usefully disordered proteins. Adv. Protein Chem. 62: 25-49.
97. Durr E, Bosshard HR. 1997. A monoclonal antibody induces opening of a coiled coil. Global protection of amide protons from H/D exchange decreases by up to 1000-fold in antibody-bound triple-stranded coiled coil. Eur. J. Biochem. 249: 325-329.
98. Dyson HJ, Wright PE. 2002a. Coupling of folding and binding for unstructured proteins. Curr. Opin. Struct. Biol. 12: 54-60.
99. Dyson HJ, Wright PE. 2002b. Insights into the structure and dynamics of unfolded proteins from nuclear magnetic resonance. Adv. Protein Chem. 62: 311-340.
100. Dyson HJ, Wright PE. 2004. Unfolded proteins and protein folding studied by NMR. Chem. Rev. 104: 3607-3622.
101. Dyson HJ, Wright PE. 2005a. Elucidation of the protein folding landscape by NMR. Meth. Enzymol. 394: 299-321.
102. Dyson HJ, Wright PE. 2005b. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 6: 197-208.
103. Ehretsmann CP, Carpousis AJ, Krisch HM. 1992. Specificity of Escherichia coli endoribonuclease RNase E: in vivo and in vitro analysis of mutants in a bacteriophage T4 mRNA processing site. Genes Dev 6: 149-159.
104. Elkins JM, Hewitson KS, McNeill LA, Seibel JF, Schlemminger I, Pugh CW, Ratcliffe PJ, Schofield CJ. 2003. Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1α. J. Biol. Chem 278: 1802-1806.
105. Ellgaard L, Frickel EM. 2003. Calnexin, calreticulin, and ERp57: teammates in glycoprotein folding. Cell Biochem. Biophys. 39: 223-247.
106. Erdös P, Rényi A. 1960. On the evolution of random graphs. Publ. Math. Inst. Hung. Acad. Sci. 5: 17-61.
107. Erlich P, Morgenroth J. 1901. Ueber Hämolysins. Fünfte Mittheiling. Berl. Klin. Wochenschr. 38: 251-257.
108. 1H NMR spectrum of a consensus DNA-binding peptide from the HMG-I protein. Bull. Magn. Reson. 14: 171-174.
109. 13C NMR assignments and molecular modelling of a minor groove DNA-binding peptide from the HMG-I protein. Int. J. Pept. Protein Res. 45: 554-560.
110. Fasman GD. 1996. Circular Dichroism and Conformational Analysis of Biomolecules. Plenum Press: New York.
111. Fedele M, Pierantoni GM, Berlingieri MT, Battista S, Baldassarre G, Munshi N, Dentice M, Thanos D, Santoro M, Viglietto G, Fusco A. 2001. Overexpression of proteins HMGA1 induces cell cycle deregulation and apoptosis in normal rat thyroid cells. Cancer Res 61: 4583-4590.
112. Ferkey DM, Kimelman D. 2002. Glycogen synthase kinase-3 beta mutagenesis identifies a common binding domain for GBP and Axin. J. Biol. Chem. 277: 16147-16152.
113. Fernandez A. 2004. Functionality of wrapping defects in soluble proteins: what cannot be kept dry must be conserved. J. Mol. Biol. 337: 477-483.
114. Fernandez A, Berry RS. 2004. Molecular dimension explored in evolution to promote proteomic complexity. Proc. Natl Acad. Sci. USA 101: 13460-13465.
115. Fernandez A, Scheraga HA. 2003. Insufficiently dehydrated hydrogen bonds as determinants of protein interactions. Proc. Natl Acad. Sci. USA 100: 113-118.
116. Fernandez A, Scott LR. 2003a. Adherence of packing defects in soluble proteins. Phys. Rev. Lett. 91: 018102.
117. Fernandez A, Scott R. 2003b. Dehydron: a structurally encoded signal for protein interaction. Biophys. J. 85: 1914-1928.
118. Fernandez A, Colubri A, Berry RS. 2002. Three-body correlations in protein folding: the origin of cooperativity. Physica A 307: 235-259.
119. Fernandez A, Scott R, Berry RS. 2004. The nonconserved wrapping of conserved protein folds reveals a trend toward increasing connectivity in proteomic networks. Proc. Natl Acad. Sci. USA 101: 2823-2827.
120. Fink AL. 2005. Natively unfolded proteins. Curr. Opin. Struct. Biol. 15: 35-41.
121. Folias A, Matkovic M, Bruun D, Reid S, Hejna J, Grompe M, D'Andrea A, Moses R. 2002. BRCA1 interacts directly with the Fanconi anemia protein FANCA. Hum. Mol. Genet. 11: 2591-2597.
122. Fontana A, Polverino de Laureto P, De Filippis V, Scaramella E, Zambonin M. 1997. Probing the partly folded states of proteins by limited proteolysis. Fold. Des. 2: R17-R26.
123. Fontana A, de Laureto PP, Spolaore B, Frare E, Picotti P, Zambonin M. 2004. Probing protein structure by limited proteolysis. Acta Biochim. Pol. 51: 299-321.
124. Foote J, Milstein C. 1994. Conformational isomerism and the diversity of antibodies. Proc. Natl Acad. Sci. USA 91: 10370-10374.
125. Fox G, Parry NR, Barnett PV, McGinn B, Rowlands DJ, Brown F. 1989. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). J. Gen. Virol. 70(Pt 3): 625-637.
126. Frame S, Cohen P, Biondi RM. 2001. A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. Mol. Cell 7: 1321-1327.
127. Frank J. 2001. Ribosomal dynamics explored by cryo-electron microscopy. Methods 25: 309-315.
128. Fraser E, Young N, Dajani R, Franca-Koh J, Ryves J, Williams RS, Yeo M, Webster MT, Richardson C, Smalley MJ, Pearl LH, Harwood A, Dale TC. 2002. Identification of the Axin and Frat binding region of glycogen synthase kinase-3. J. Biol. Chem. 277: 2176-2185.
129. Freed EO, Myers DJ, Risser R. 1991. Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain. J. Virol. 65: 190-194.
130. Frelinger AL 3rd, Cohen I, Plow EF, Smith MA, Roberts J, Lam SC, Ginsberg MH. 1990. Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers. J. Biol. Chem. 265: 6346-6352.
131. Frelinger AL 3rd, Du XP, Plow EF, Ginsberg MH. 1991. Monoclonal antibodies to ligand-occupied conformers of integrin alpha Mb beta 3 (glycoprotein IIb-IIIa) alter receptor affinity, specificity, and function. J. Biol. Chem. 266: 17106-17111.
132. Fried MG, Stickle DF, Smirnakis KV, Adams C, MacDonald D, Lu P. 2002. Role of hydration in the binding of lac repressor to DNA. J. Biol. Chem. 277: 50676-50682.
133. Fujita N, Endo S, Ishihama A. 2000. Structural requirements for the interdomain linker of alpha subunit of Escherichia coli RNA polymerase. Biochemistry 39: 6243-6249.
134. Gabus C, Derrington E, Leblanc P, Chnaiderman J, Dormont D, Swietnicki W, Morillas M, Surewicz WK, Marc D, Nandi P, Darlix JL. 2001. The prion protein has RNA binding and chaperoning properties characteristic of nucleocapsid protein NCP7 of HIV-1. J. Biol. Chem. 276: 19301-19309.
135. Garcia-Dominguez M, Reyes JC, Florencio FJ. 1999. Glutamine synthetase inactivation by protein-protein interaction. Proc. Natl Acad. Sci. USA 96: 7161-7166.
136. Garner E, Romero P, Dunker AK, Brown C, Obradovic Z. 1999. Predicting binding regions within disordered proteins. Genome Inform. Ser. Workshop Genome Inform. 10: 41-50.
137. Gatei M, Scott SP, Filippovitch I, Soronika N, Lavin MF, Weber B, Khanna KK. 2000. Role for ATM in DNA damage-induced phosphorylation of BRCA1. Cancer Res. 60: 3299-3304.
138. Gatei M, Zhou BB, Hobson K, Scott S, Young D, Khanna KK. 2001. Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies. J. Biol. Chem. 276: 17276-17280.
139. Giancotti V, Buratti E, Perissin L, Zorzet S, Balmain A, Portella G, Fusco A, Goodwin GH. 1989. Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures. Exp. Cell Res. 184: 538-545.
140. Giancotti V, Bandiera A, Buratti E, Fusco A, Marzari R, Coles B, Goodwin GH. 1991. Comparison of multiple forms of the high mobility group I proteins in rodent and human cells. Identification of the human high mobility group I-C protein. Eur. J. Biochem. 198: 211-216.
141. Gillen KL, Hughes KT. 1991. Negative regulatory loci coupling flagellin synthesis to flagellar assembly in Salmonella typhimurium. J. Bacteriol. 173: 2301-2310.
142. Glatter O, Kratky O. 1982. Small Angle X-ray Scattering. Academic Press: London.
143. Goh KI, Oh E, Jeong H, Kahng B, Kim D. 2002. Classification of scale-free networks. Proc. Natl Acad. Sci. USA 99: 12583-12588.
144. Gorovits BM, Horowitz PM. 1995. The molecular chaperonin cpn60 displays local flexibility that is reduced after binding with an unfolded protein. J. Biol. Chem. 270: 13057-13062.
145. Green TB, Ganesh O, Perry K, Smith L, Phylip LH, Logan TM, Hagen SJ, Dunn BM, Edison AS. 2004. IA3, an aspartic proteinase inhibitor from Saccharomyces cerevisiae, is intrinsically unstructured in solution. Biochemistry 43: 4071-4081.
146. Grosschedl R, Giese K, Pagel J. 1994. HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet. 10: 94-100.
147. Gudkov AT, Gongadze GM. 1984. The L7/L12 proteins change their conformation upon interaction of EF-G with ribosomes. FEBS Lett. 176: 32-36.
148. Guermeur Y. 1997. Combinaison de classifieurs statistiques, Application a la prediction de structure secondaire des proteines. These de Doctorat de l'Universite Paris 6, Paris.
149. Gunasekaran K, Tsai CJ, Kumar S, Zanuy D, Nussinov R. 2003. Extended disordered proteins: targeting function with less scaffold. Trends Biochem. Sci. 28: 81-85.
150. Gusev NB. 2001. Some properties of caldesmon and calponin and the participation of these proteins in regulation of smooth muscle contraction and cytoskeleton formation. Biochemistry (Mosc.) 66: 1112-1121.
151. Hamman BD, Oleinikov AV, Jokhadze GG, Traut RR, Jameson DM. 1996a. Dimer/monomer equilibrium and domain separations of Escherichia coli ribosomal protein L7/L12. Biochemistry 35: 16680-16686.
152. Hamman BD, Oleinikov AV, Jokhadze GG, Traut RR, Jameson DM. 1996b. Rotational and conformational dynamics of Escherichia coli ribosomal protein L7/L12. Biochemistry 35: 16672-16679.
153. Han JD, Bertin N, Hao T, Goldberg DS, Berriz GF, Zhang LV, Dupuy D, Walhout AJ, Cusick ME, Roth FP, Vidal M. 2004. Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature 430: 88-93.
154. Hanski E, Horwitz PA, Caparon MG. 1992. Expression of protein F, the fibronectin-binding protein of Streptococcus pyogenes JRS4, in heterologous streptococcal and enterococcal strains promotes their adherence to respiratory epithelial cells. Infect. Immunol. 60: 5119-5125.
155. Harms J, Schluenzen F, Zarivach R, Bashan A, Gat S, Agmon I, Bartels H, Franceschi F, Yonath A. 2001. High resolution structure of the large ribosomal subunit from a mesophilic eubacterium. Cell 107: 679-688.
156. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
157. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E, Fox MP, Wei N. 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell. 6: 387-400.
158. Hart MJ, de los Santos R, Albert IN, Rubinfeld B, Polakis P. 1998. Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Curr. Biol. 8: 573-581.
159. Hartwell LH, Hopfield JJ, Leibler S, Murray AW. 1999. From molecular to modular cell biology. Nature 402: C47-C52.
160. 2- and COOH-terminal domains for interactions with the nucleoprotein (N) but only the COOH terminus for interactions with itself. J. Gen. Virol. 76(Pt 11): 2863-2867.
161. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW. 1998. Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512.
162. Hernandez MA, Avila J, Andreu JM. 1986. Physicochemical characterization of the heat-stable microtubule-associated protein MAP2. Eur. J. Biochem. 154: 41-48.
163. Holt C, Sawyer L. 1993. Caseins as rheomorphic proteins: interpretation of primary and secondary structures of the αs1-, β-, and κ-caseins. J. Chem. Soc. Faraday Trans. 89: 2683-2692.
164. Hopp TP, Woods KR. 1981. Prediction of protein antigenic determinants from amino acid sequences. Proc. Natl Acad. Sci. USA 78: 3824-3828.
165. Hopp TP, Woods KR. 1983. A computer program for predicting protein antigenic determinants. Mol. Immunol. 20: 483-489.
166. Horwitz J. 2003. Alpha-crystallin. Exp. Eye Res. 76: 145-153.
167. Hoshi T, Zagotta WN, Aldrich RW. 1990. Biophysical and molecular mechanisms of Shaker potassium channel inactivation. Science 250: 533-538.
168. House-Pompeo K, Xu Y, Joh D, Speziale P, Hook M. 1996. Conformational changes in the fibronectin binding MSCRAMMs are induced by ligand binding. J. Biol. Chem. 271: 1379-1384.
169. Hsu W, Zeng L, Costantini F. 1999. Identification of a domain of Axin that binds to the serine/threonine protein pnosphatase 2A and a self-binding domain. J. Biol. Chem. 274: 3439-3445.
170. Hu YF, Li R. 2002. JunB potentiates function of BRCA1 activation domain 1 (AD1) through a coiled-coil-mediated interaction. Genes Dev. 16: 1509-1517.
171. Huang H, Liao J, Cohen SN. 1998. Poly(A)- and poly(U)-specific RNA 3′ tail shortening by E. coli ribonuclease E. Nature 391: 99-102.
172. Hubbard JA, Martin SR, Chaplin LC, Bose C, Kelly SM, Price NC. 1991. Solution structures of calcitonin-gene-related-peptide analogues of calcitonin-gene-related peptide and amylin. Biochem. J. 275(Pt 3): 785-788.
173. Hubbard JA, Raleigh DP, Bonnerjea JR, Dobson CM. 1997. Identification of the epitopes of calcitonin gene-related peptide (CGRP) for two anti-CGRP monoclonal antibodies by 2D NMR. Protein Sci. 6: 1945-1952.
174. Hubbard SJ, Eisenmenger F, Thornton JM. 1994. Modeling studies of the change in conformation required for cleavage of limited proteolytic sites. Protein Sci. 3: 757-768.
175. Hughes KT, Gillen KL, Semon MJ, Karlinsey JE. 1993. Sensing structural intermediates in bacterial flagellar assembly by export of a negative regulator. Science 262: 1277-1280.
176. Hultschig C, Hecht HJ, Frank R. 2004. Systematic delineation of a calmodulin peptide interaction. J. Mol. Biol. 343: 559-568.
177. Huth JR, Bewley CA, Nissen MS, Evans JN, Reeves R, Gronenborn AM, Clore GM. 1997. The solution structure of an HMG-I(Y)-DNA complex defines a new architectural minor groove binding motif. Nat. Struct. Biol. 4: 657-665.
178. Iakoucheva LM, Kimzey AL, Masselon CD, Smith RD, Dunker AK, Ackerman EJ. 2001. Aberrant mobility phenomena of the DNA repair protein XPA. Protein Sci. 10: 1353-1362.
179. Iakoucheva LM, Brown CJ, Lawson JD, Obradovic Z, Dunker AK. 2002. Intrinsic disorder in cell-signaling and cancer-associated proteins. J. Mol. Biol. 323: 573-584.
180. Igarashi K, Hanamura A, Makino K, Aiba H, Mizuno T, Nakata A, Ishihama A. 1991. Functional map of the alpha subunit of Escherichia coli RNA polymerase: two modes of transcription activation by positive factors. Proc. Natl Acad. Sci. USA 88: 8958-8962.
181. Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, Kikuchi A. 1998. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. Embo J. 17: 1371-1384.
182. Jackson RJ. 1996. A comparative view of initiation site selection mechanisms. In Translational Control, Hershey JWB, Mathews MB, Sonenberg N (eds). Cold Spring Harbor Laboratory Press: New York; 71-112.
183. Jacob F, Monod J. 1961. Genetic regulatory mechanisms in the synthesis of proteins. J. Mol. Biol. 3: 318-356.
184. Jain C, Deana A, Belasco JG. 2002. Consequences of RNase E scarcity in Escherichia coli. Mol. Microbiol. 43: 1053-1064.
185. James LC, Tawfik DS. 2003. Conformational diversity and protein evolution - a 60-year-old hypothesis revisited. Trends Biochem. Sci. 28: 361-368.
186. James LC, Roversi P, Tawfik DS. 2003. Antibody multispecificity mediated by conformational diversity. Science 299: 1362-1367.
187. Javaherian K, Langlois AJ, McDanal C, Ross KL, Eckler LI, Jellis CL, Profy AT, Rusche JR, Bolognesi DP, Putney SD. 1989. Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc. Natl Acad. Sci. USA 86: 6768-6772.
188. Jeffrey PD, Gorina S, Pavletich NP. 1995. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science 267: 1498-1502.
189. Jemmerson R. 1987. Antigenicity and native structure of globular proteins: low frequency of peptide reactive antibodies. Proc. Natl Acad. Sci. USA 84: 9180-9184.
190. Jeong H, Mason SP, Barabasi AL, Oltvai ZN. 2001. Lethality and centrality in protein networks. Nature 411: 41-42.
191. Jimenez R, Salazar G, Baldridge KK, Romesberg FE. 2003. Flexibility and molecular recognition in the immune system. Proc. Natl Acad. Sci. USA 100: 92-97.
192. Jimenez R, Salazar G, Yin J, Joo T, Romesberg FE. 2004. Protein dynamics and the immunological evolution of molecular recognition. Proc. Natl Acad. Sci. USA 101: 3803-3808.
193. Johansson K, Bourhis JM, Campanacci V, Cambillau C, Canard B, Longhi S. 2003. Crystal structure of the measles virus phosphoprotein domain responsible for the induced folding of the C-terminal domain of the nucleoprotein. J. Biol. Chem. 278: 44567-44573.
194. Jones DT. 1999. Protein secondary structure prediction based on position-specific scoring matrices. J. Mol. Biol. 292: 195-202.
195. Jones DT, Ward JJ. 2003. Prediction of disordered regions in proteins from position specific score matrices. Proteins 53(suppl. 6): 573-578.
196. Kaberdin VR, Miczak A, Jakobsen JS, Lin-Chao S, McDowall KJ, von Gabain A. 1998. The endoribonucleolytic N-terminal half of Escherichia coli RNase E is evolutionary conserved in Synechocystis sp. and other bacteria but not the C-terminal half, which is sufficient for degradosome assembly. Proc. Natl Acad. Sci. USA 95: 11637-11642.
197. Karplus PA, Schulz GE. 1985. Prediction of chain flexibility in proteins. Naturwissenschaften 72: 213-213.
198. Keitel T, Kramer A, Wessner H, Scholz C, Schneider-Mergener J, Hohne W. 1997. Crystallographic analysis of anti-p24 (HIV-1) monoclonal antibody cross-reactivity and polyspecificity. Cell 91: 811-820.
199. Kercher MA, Lu P, Lewis M. 1997. Lac repressor-operator complex. Curr. Opin. Struct. Biol. 7: 76-85.
200. Kerr P, Ashworth A. 2001. New complexities for BRCA1 and BRCA2. Curr. Biol. 11: R668-R676.
201. Kim TD, Paik SR, Yang CH. 2002. Structural and functional implications of C-terminal regions of alpha-synuclein. Biochemistry 41: 13782-13790.
202. Kingston RL, Hamel DJ, Gay LS, Dahlquist FW, Matthews BW. 2004. Structural basis for the attachment of a paramyxoviral polymerase to its template. Proc. Natl Acad. Sci. USA 101: 8301-8306.
203. Koshland DE Jr, Ray WJ Jr, Erwin MJ. 1958. Protein structure and enzyme action. Fed. Proc. 17: 1145-1150.
204. Kramer A, Keitel T, Winkler K, Stocklein W, Hohne W, Schneider-Mergener J. 1997. Molecular basis for the binding promiscuity of an anti-p24 (HIV-1) monoclonal antibody. Cell 91: 799-809.
205. Krapivsky PL, Redner S, Leyvraz F. 2000. Connectivity of growing random networks. Phys. Rev. Lett. 85: 4629-4632.
206. Kriwacki RW, Hengst L, Tennant L, Reed SI, Wright PE. 1996. Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity. Proc. Natl Acad. Sci. USA 93: 11504-11509.
207. Kuehl L, Salmond B, Tran L. 1984. Concentrations of high-mobility-group proteins in the nucleus and cytoplasm of several rat tissues. J. Cell Biol. 99: 648-654.
208. Kundu S, Melton JS, Sorensen DC, Phillips GN Jr. 2002. Dynamics of proteins in crystals: comparison of experiment with simple models. Biophys. J. 83: 723-732.
209. Kushner SR. 2002. mRNA decay in Escherichia coli comes of age. J. Bacteriol. 184: 4658-4665.
210. Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ, Pavletich NP. 1996. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274: 948-953.
211. Kutsukake K. 1994. Excretion of the anti-sigma factor through a flagellar substructure couples flagellar gene expression with flagellar assembly in Salmonella typhimurium. Mol. Gen. Genet. 243: 605-612.
212. 2+-binding protein (10.5 kDa) from Ehrlich-ascites-tumour cells. Biochem. J. 247: 663-667.
213. Lamb RA, Kolakofsky D. 2001. Paramyxoviridae: the viruses and their replication. In Fields Virology, Fields BN, Knipe DM, Howley PM (eds). Lippincott Williams & Wilkins: Philadelphia, PA; 1303-1340.
214. Landsteiner K. 1901. Über Agglutinationserscheinungen normalen menschlichen Blutes. Wien. Klin. Wochenschr. 14: 1132-1134.
215. Landsteiner K. 1936. The Specificity of Serological Reactions. Dover: New York.
216. Lane DP. 1992. Cancer. p53, guardian of the genome. Nature 358: 15-16.
217. LaRosa GJ, Davide JP, Weinhold K, Waterbury JA, Profy AT, Lewis JA, Langlois AJ, Dreesman GR, Boswell RN, Shadduck P, Holley LH, Karplus M, Bolognesi DP, Matthews TJ, Emini EA, Putney SD. 1990. Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science 249: 932-935.
218. Lasky LA, Nakamura G, Smith DH, Fennie C, Shimasaki C, Patzer E, Berman P, Gregory T, Capon DJ. 1987. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 50: 975-985.
219. Lawrence MC, Colman PM. 1993. Shape complementarity at protein/protein interfaces. J. Mol. Biol. 234: 946-950.
220. Lea S, Hernandez J, Blakemore W, Brocchi E, Curry S, Domingo E, Fry E, Abu-Ghazaleh R, King A, Newman J, Stuart D, Mateu MG. 1994. The structure and antigenicity of a type C foot-and-mouth disease virus. Structure 2: 123-139.
221. Lea S, Abu-Ghazaleh R, Blakemore W, Curry S, Fry E, Jackson T, King A, Logan D, Newman J, Stuart D. 1995. Structural comparison of two strains of foot-and-mouth disease virus subtype O1 and a laboratory antigenic variant, G67. Structure 3: 571-580.
222. Leder L, Berger C, Bornhauser S, Wendt H, Ackermann F, Jelesarov I, Bosshard HR. 1995. Spectroscopic, calorimetric, and kinetic demonstration of conformational adaptation in peptide-antibody recognition. Biochemistry 34: 16509-16518.
223. Lee B, Richards FM. 1971. The interpretation of protein structures: estimation of static accessibility. J. Mol. Biol. 55: 379-400.
224. Lee C, Kim SJ, Jeong DG, Lee SM, Ryu SE. 2003. Structure of human FIH-1 reveals a unique active site pocket and interaction sites for HIF-1 and von Hippel-Lindau. J. Biol. Chem 278: 7558-7563.
225. Lee H, Mok KH, Muhandiram R, Park KH, Suk JE, Kim DH, Chang J, Sung YC, Choi KY, Han KH. 2000a. Local structural elements in the mostly unstructured transcriptional activation domain of human p53. J. Biol. Chem. 275: 29426-29432.
226. Lee JS, Collins KM, Brown AL, Lee CH, Chung JH. 2000b. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature 404: 201-204.
227. Lee K, Bernstein JA, Cohen SN. 2002. RNase G complementation of rne null mutation identifies functional interrelationships with RNase E in Escherichia coli. Mol. Microbiol. 43: 1445-1456.
228. Lehn DA, Elton TS, Johnson KR, Reeves R. 1988. A conformational study of the sequence specific binding of HMG-I (Y) with the bovine interleukin-2 cDNA. Biochem. Int. 16: 963-971.
229. Levine AJ. 1997. p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
230. Lewis M, Chang G, Horton NC, Kercher MA, Pace HC, Schumacher MA, Brennan RG, Lu P. 1996. Crystal structure of the lactose operon repressor and its complexes with DNA and inducer. Science 271: 1247-1254.
231. Li L, Yuan H, Weaver CD, Mao J, Farr GH 3rd, Sussman DJ, Jonkers J, Kimelman D, Wu D. 1999a. Axin and Frat1 interact with dvl and GSK, bridging Dvl to GSK in Wnt-mediated regulation of LEF-1. Embo J. 18: 4233-4240.
232. Li M, Phylip LH, Lees WE, Winther JR, Dunn BM, Wlodawer A, Kay J, Gustchina A. 2000. The aspartic proteinase from Saccharomyces cerevisiae folds its own inhibitor into a helix. Nat. Struct. Biol. 7: 113-117.
233. Li X, Romero P, Rani M, Dunker AK, Obradovic Z. 1999b. Predicting protein disorder for N-, C-, and internal regions. Genome Inform. Ser. Workshop Genome Inform. 10: 30-40.
234. Liebovitch LS, Selector LY, Kline RP. 1992. Statistical properties predicted by the ball and chain model of channel inactivation. Biophys. J. 63: 1579-1585.
235. Linderstrøm-Lang KU, Schellman JA. 1959. Protein structure and enzyme activity. In The Enzymes, Boyer PD, Lardy H, Myrback K (eds). Academic Press: New York; 443-510.
236. Lindgren PE, McGavin MJ, Signas C, Guss B, Gurusiddappa S, Hook M, Lindberg M. 1993. Two different genes coding for fibronectin-binding proteins from Streptococcus dysgalactiae. The complete nucleotide sequences and characterization of the binding domains. Eur. J. Biochem. 214: 819-827.
237. Linding R, Jensen LJ, Diella F, Bork P, Gibson TJ, Russell RB. 2003a. Protein disorder prediction: implications for structural proteomics. Structure (Camb.) 11: 1453-1459.
238. Linding R, Russell RB, Neduva V, Gibson TJ. 2003b. GlobPlot: exploring protein sequences for globularity and disorder. Nucl. Acids Res. 31: 3701-3708.
239. Lindner RA, Carver JA, Ehrnsperger M, Buchner J, Esposito G, Behlke J, Lutsch G, Kotlyarov A, Gaestel M. 2000. Mouse Hsp25, a small shock protein. The role of its C-terminal extension in oligomerization and chaperone action. Eur. J. Biochem. 267: 1923-1932.
240. Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, Zhang Z, Lin X, He X. 2002a. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108: 837-847.
241. Liu J, Rost B. 2001. Comparing function and structure between entire proteomes. Protein Sci. 10: 1970-1979.
242. Liu J, Rost B. 2003. NORSp: Predictions of long regions without regular secondary structure. Nucl. Acids Res. 31: 3833-3835.
243. Liu J, Tan H, Rost B. 2002b. Loopy proteins appear conserved in evolution. J. Mol. Biol. 322: 53-64.
244. Logan D, Abu-Ghazaleh R, Blakemore W, Curry S, Jackson T, King A, Lea S, Lewis R, Newman J, Parry N et al. 1993. Structure of a major immunogenic site on foot-and-mouth disease virus. Nature 362: 566-568.
245. Longhi S, Receveur-Brechot V, Karlin D, Johansson K, Darbon H, Bhella D, Yeo R, Finet S, Canard B. 2003. The C-terminal domain of the measles virus nucleoprotein is intrinsically disordered and folds upon binding to the C-terminal moiety of the phosphoprotein. J. Biol. Chem. 278: 18638-18648.
246. Lopez PJ, Marchand I, Joyce SA, Dreyfus M. 1999. The C-terminal half of RNase E, which organizes the Escherichia coli degradosome, participates in mRNA degradation but not rRNA processing in vivo. Mol. Microbiol. 33: 188-199.
247. Lund T, Holtlund J, Fredriksen M, Laland SG. 1983. On the presence of two new high mobility group-like proteins in HeLa S3 cells. FEBS Lett. 152: 163-167.
248. Lupas A, Van Dyke M, Stock J. 1991. Predicting coiled coils from protein sequences. Science 252: 1162-1164.
249. Ma B, Shatsky M, Wolfson HJ, Nussinov R. 2002. Multiple diverse ligands binding at a single protein site: a matter of pre-existing populations. Protein Sci. 11: 184-197.
250. Manalan AS, Klee CB. 1983. Activation of calcineurin by limited proteolysis. Proc. Natl Acad. Sci. USA 80: 4291-4295.
251. Mani RS, Kay CM. 1996. Calcium binding proteins. In Biochemistry of Smooth Muscle Contraction, Barany M (ed.). Academic Press/Elsevier: New York; 105-116.
252. Manke IA, Lowery DM, Nguyen A, Yaffe MB. 2003. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science 302: 636-639.
253. Mark WY, Liao JC, Lu Y, Ayed A, Laister R, Szymczyna B, Chakrabartty A, Arrowsmith CH. 2005. Characterization of segments from the central region of BRCA1: an intrinsically disordered scaffold for multiple protein-protein and protein-DNA interactions? J. Mol. Biol. 345: 275-287.
254. Markus G. 1965. Protein substrate conformation and proteolysis. Proc. Natl Acad. Sci. USA 54: 253-258.
255. Markus MA, Hinck AP, Huang S, Draper DE, Torchia DA. 1997. High resolution solution structure of ribosomal protein L11-C76, a helical protein with a flexible loop that becomes structured upon binding to RNA. Nat. Struct. Biol. 4: 70-77.
256. Marston SB, Redwood CS. 1991. The molecular anatomy of caldesmon. Biochem. J. 279(Pt 1): 1-16.
257. Matsushita S, Robert-Guroff M, Rusche J, Koito A, Hattori T, Hoshino H, Javaherian K, Takatsuki K, Putney S. 1988. Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope. J. Virol. 62: 2107-2114.
258. McDowall KJ, Cohen SN. 1996. The N-terminal domain of the rne gene product has RNase E activity and is non-overlapping with the arginine-rich RNA-binding site. J. Mol. Biol. 255: 349-355.
259. Meador WE, Means AR, Quiocho FA. 1992. Target enzyme recognition by calmodulin: 2.4 Å structure of a calmodulin-peptide complex. Science 257: 1251-1255.
260. Melamud E, Moult J. 2003. Evaluation of disorder predictions in CASP5. Proteins 53(suppl. 6): 561-565.
261. Meurs E, Chong K, Galabru J, Thomas NS, Kerr IM, Williams BR, Hovanessian AG. 1990. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 62: 379-390.
262. Midgley CA, Desterro JM, Saville MK, Howard S, Sparks A, Hay RT, Lane DP. 2000. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo. Oncogene 19: 2312-2323.
263. Mikhalyi E. 1978. Application of Proteolytic Enzymes to Protein Structure Studies. CRC Press: Boca Raton, FL.
264. Milgram S. 1967. The small world problem. Psychol. Today 2: 60-67.
265. Montesano-Roditis L, Glitz DG, Traut RR, Stewart PL. 2001. Cryo-electron microscopic localization of protein L7/L12 within the Escherichia coli 70 S ribosome by difference mapping and Nanogold labeling. J. Biol. Chem. 276: 14117-14123.
266. Moore PB, Steitz TA. 2003. The structural basis of large ribosomal subunit function. A. Rev. Biochem. 72: 813-850.
267. 1H NMR. Embo J. 11: 3059-3065.
268. Munier H, Bouhss A, Gilles AM, Krin E, Glaser P, Danchin A, Barzu O. 1993. Structural flexibility of the calmodulin-binding locus in Bordetella pertussis adenylate cyclase. Reconstitution of catalytically active species from fragments or inactive forms of the enzyme. Eur. J. Biochem. 217: 581-586.
269. Muro-Pastor MI, Barrera FN, Reyes JC, Florencio FJ, Neira JL. 2003. The inactivating factor of glutamine synthetase, IF7, is a "natively unfolded" protein. Protein Sci. 12: 1443-1454.
270. Namba K. 2001. Roles of partly unfolded conformations in macromolecular self-assembly. Genes Cells 6: 1-12.
271. Nanduri S, Carpick BW, Yang Y, Williams BR, Qin J. 1998. Structure of the double-stranded RNA-binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation. Embo J. 17: 5458-5465.
272. Nett JH, Hunte C, Trumpower BL. 2000. Changes to the length of the flexible linker region of the Rieske protein impair the interaction of ubiquinol with the cytochrome bc1 complex. Eur. J. Biochem. 267: 5777-5782.
273. Nishio M, Tsurudome M, Ito M, Kawano M, Kusagawa S, Komada H, Ito Y. 1999. Mapping of domains on the human parainfluenza virus type 2 nucleocapsid protein (NP) required for NP-phosphoprotein or NP-NP interaction. J. Gen. Virol. 80(Pt 8): 2017-2022.
274. Nisonoff A, Reichlin M, Margoliash E. 1970. Immunological activity of cytochrome c. II. Localization of a major antigenic determinant of human cytochrome c. J. Biol. Chem. 245: 940-946.
275. Notkins AL. 2004. Polyreactivity of antibody molecules. Trends Immunol. 25: 174-179.
276. Obradovic Z, Peng K, Vucetic S, Radivojac P, Brown CJ, Dunker AK. 2003. Predicting intrinsic disorder from amino acid sequence. Proteins 53(suppl. 6): 566-572.
277. O'Connor T, Lawson JD, Dunker AK. 2002. The benefit of disorder information in neural network prediction of calmodulin binding targets. Int. Joint Conf. Neural Networks 5: 299.
278. Ohnishi K, Kutsukake K, Suzuki H, Iino T. 1990. Gene fliA encodes an alternative sigma factor specific for flagellar operons in Salmonella typhimurium. Mol. Gen. Genet. 221: 139-147.
279. Oldfield CJ. 2002. Predictions of disordered proteins and protein binding regions: applications to structural genomics. Honors College Thesis. Washington State University.
280. Oldfield CJ, Cheng Y, Cortese MS, Brown CJ, Uversky VN, Dunker AK. 2005a. Comparing and combining predictors of mostly disordered proteins. Biochemistry 44: 1989-2000.
281. Oldfield CJ, Cheng Y, Cortese MS, Romero P, Uversky VN, Dunker AK. 2005b. Coupled folding and binding with α-helix-forming molecular recognition elelmts. Biochemistry (in press).
282. Oleinikov AV, Jokhadze GG, Traut RR. 1998. A single-headed dimer of Escherichia coli ribosomal protein L7/L12 supports protein synthesis. Proc. Natl Acad. Sci. USA 95: 4215-4218.
283. O'Neil KT, DeGrado WF. 1990. How calmodulin binds its targets: sequence independent recognition of amphiphilic alpha-helices. Trends Biochem. Sci. 15: 59-64.
284. O'Neil KT, Hoess RH, DeGrado WF. 1990. Design of DNA-binding peptides based on the leucine zipper motif. Science 249: 774-778.
285. Ono M, Kuwano M. 1979. A conditional lethal mutation in an Escherichia coli strain with a longer chemical lifetime of messenger RNA. J. Mol. Biol. 129: 343-357.
286. Ow MC, Kushner SR. 2002. Initiation of tRNA maturation by RNase E is essential for cell viability in E. coli. Genes Dev. 16: 1102-1115.
287. Park SM, Jung HY, Kim TD, Park JH, Yang CH, Kim J. 2002. Distinct roles of the N-terminal-binding domain and the C-terminal-solubilizing domain of alpha-synuclein, a molecular chaperone. J. Biol. Chem. 277: 28512-28520.
288. Parry NR, Barnett PV, Ouldridge EJ, Rowlands DJ, Brown F. 1989. Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents. J. Gen. Virol. 70(Pt 6): 1493-1503.
289. Parry N, Fox G, Rowlands D, Brown F, Fry E, Acharya R, Logan D, Stuart D. 1990. Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus. Nature 347: 569-572.
290. Parsegian VA, Rand RP, Fuller NL, Rau DC. 1986. Osmotic stress for the direct measurement of intermolecular forces. Meth. Enzymol. 127: 400-416.
291. Parsegian VA, Rand RP, Rau DC. 1995. Macromolecules and water: probing with osmotic stress. Meth. Enzymol. 259: 43-94.
292. Parsegian VA, Rand RP, Rau DC. 2000. Osmotic stress, crowding, preferential hydration, and binding: A comparison of perspectives. Proc. Natl Acad. Sci. USA 97: 3987-3992.
293. Patti JM, Allen BL, McGavin MJ, Hook M. 1994. MSCRAMM-mediated adherence of microorganisms to host tissues. A. Rev. Microbiol. 48: 585-617.
294. Pauling L. 1940. A theory of the structure and process of formation of antibodies. J. Am. Chem. Soc. 62: 2643-2657.
295. Paull TT, Cortez D, Bowers B, Elledge SJ, Gellert M. 2001. Direct DNA binding by Brca1. Proc. Natl Acad. Sci. USA 98: 6086-6091.
296. Pe'er I, Felder CE, Man O, Silman I, Sussman JL, Beckmann JS. 2004. Proteomic signatures: amino acid and oligopeptide compositions differentiate among phyla. Proteins 54: 20-40.
297. Pellequer JL, Westhof E, Van Regenmortel MHV. 1994. Epitope predictions from the primary structure of proteins. In Peptide Antigens: a Practical Approach, Wisdom GB (eds). Oxford University Press: Oxford; 7-25.
298. Peng K, Vucetic S, Radivojac P, Brown CJ, Dunker AK, Obradovic Z. 2005. Optimizing long intrinsic disorder predictors with protein evolutionary information. J. Bioinform. Comput. Biol. 3: 35-60.
299. Penkett CJ, Redfield C, Jones JA, Dodd I, Hubbard J, Smith RA, Smith LJ, Dobson CM. 1998. Structural and dynamical characterization of a biologically active unfolded fibronectin-binding protein from Staphylococcus aureus. Biochemistry 37: 17054-17067.
300. Permyakov SE, Millett IS, Doniach S, Permyakov EA, Uversky VN. 2003. Natively unfolded C-terminal domain of caldesmon remains substantially unstructured after the effective binding to calmodulin. Proteins 53: 855-862.
301. Petros AM, Nettesheim DG, Wang Y, Olejniczak ET, Meadows RP, Mack J, Swift K, Matayoshi ED, Zhang H, Thompson CB, Fesik SW. 2000. Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies. Protein Sci. 9: 2528-2534.
302. Pettersson I, Kurland CG. 1980. Ribosomal protein L7/L12 is required for optimal translation. Proc. Natl Acad. Sci. USA 77: 4007-4010.
303. Pfaff E, Mussgay M, Bohm HO, Schulz GE, Schaller H. 1982. Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. Embo J. 1: 869-874.
304. Picard D, Bunone G, Liu JW, Donze O. 1997. Steroid-independent activation of steroid receptors in mammalian and yeast cells and in breast cancer. Biochem. Soc. Trans. 25: 597-602.
305. Pierce AJ, Stark JM, Araujo FD, Moynahan ME, Berwick M, Jasin M. 2001. Double-strand breaks and tumorigenesis. Trends Cell Biol. 11: S52-S59.
306. Pinilla C, Chendra S, Appel JR, Houghten RA. 1995. Elucidation of monoclonal antibody polyspecificity using a synthetic combinatorial library. Pept. Res. 8: 250-257.
307. Plyte SE, Hughes K, Nikolakaki E, Pulverer BJ, Woodgett JR. 1992. Glycogen synthase kinase-3: functions in oncogenesis and development. Biochim. Biophys. Acta 1114: 147-162.
308. Podlaha O, Zhang J. 2003. Positive selection on protein-length in the evolution of a primate sperm ion channel. Proc. Natl Acad. Sci. USA 100: 12241-12246.
309. Polakis P. 2000. Wnt signaling and cancer. Genes Dev. 14: 1837-1851.
310. Polyakov AA, Huber PA, Marston SB, Gusev NB. 1998. Interaction of isoforms of S100 protein with smooth muscle caldesmon. FEBS Lett. 422: 235-239.
311. Pontius BW. 1993. Close encounters: why unstructured, polymeric domains can increase rates of specific macromolecular association. Trends Biochem. Sci. 18: 181-186.
312. Pontius BW, Berg P. 1990. Renaturation of complementary DNA strands mediated by purified mammalian heterogeneous nuclear ribonucleoprotein A1 protein: implications for a mechanism for rapid molecular assembly. Proc. Natl Acad. Sci. USA 87: 8403-8407.
313. Portner A, Murti KG, Morgan EM, Kingsbury DW. 1988. Antibodies against Sendai virus L protein: distribution of the protein in nucleocapsids revealed by immunoelectron microscopy. Virology 163: 236-239.
314. Prilunski J, Felder CE, Zeev-Ben-Mordehai T, Rydberg EH, Man O, Beckman JS, Silman I, Sussman JL 2005. FoldIndex© predicts whether a given protein is intrinsically disordered. Bioinformatics (in press).
315. Privalov PL. 1979. Stability of proteins: small globular proteins. Adv. Protein Chem. 33: 167-241.
316. Prives C, Hall PA. 1999. The p53 pathway. J. Pathol. 187: 112-126.
317. Provencher SW, Glockner J. 1981. Estimation of globular protein secondary structure from circular dichroism. Biochemistry 20: 33-37.
318. Ptitsyn OB. 1995. Molten globule and protein folding. Adv. Protein Chem. 47: 83-229.
319. Ptitsyn OB, Uversky VN. 1994. The molten globule is a third thermodynamical state of protein molecules. FEBS Lett. 341: 15-18.
320. Pullen RA, Jenkins JA, Tickle IJ, Wood SP, Blundell TL 1975. The relation of polypeptide hormone structure and flexibility to receptor binding: the relevance of X-ray studies on insulins, glucagon and human placental lactogen. Mol. Cell Biochem. 8: 5-20.
321. Putney SD, Matthews TJ, Robey WG, Lynn DL, Robert-Guroff M, Mueller WT, Langlois AJ, Ghrayeb J, Petteway SR Jr, Weinhold KJ, Fischinger PJ, Wong-Staal F, Gallo RC, Bolognesi DP. 1986. HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope. Science 234: 1392-1395.
322. Qin H, Lu HH, Wu WB, Li WH. 2003. Evolution of the yeast protein interaction network. Proc. Natl Acad. Sci. USA 100: 12820-12824.
323. Radivojac P, Obradovic Z, Smith DK, Zhu G, Vucetic S, Brown CJ, Lawson JD, Dunker AK. 2004. Protein flexibility and intrinsic disorder. Protein Sci. 13: 71-80.
324. Ramsland PA, Guddat LW, Edmundson AB, Raison RL. 1997. Diverse binding site structures revealed in homology models of polyreactive immunoglobulins. J. Comput. Aided Mol. Des. 11: 453-461.
325. 2+ pump of higher plants (a comparison with the effect of calmodulin in plasma membrane from radish seedlings). Plant Physiol. 103: 385-390.
326. Raynaud A, Cohen R, Modigliani E. 1994. Calcitonin gene-related peptide (CGRP). Presse Med. 23: 171-175.
327. Reeves R. 1992. Chromatin changes during the cell cycle. Curr. Opin. Cell. Biol. 4: 413-423.
328. Reeves R. 2001. Molecular biology of HMGA proteins: hubs of nuclear function. Gene 277: 63-81.
329. Reeves R, Beckerbauer L. 2001. HMGI/Y proteins: flexible regulators of transcription and chromatin structure. Biochim. Biophys. Acta 1519: 13-29.
330. Reeves R, Nissen MS. 1990. The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure. J. Biol. Chem. 265: 8573-8582.
331. Reeves R, Nissen MS. 1993. Interaction of high mobility group-I (Y) nonhistone proteins with nucleosome core particles. J. Biol. Chem. 268: 21137-21146.
332. Reeves R, Nissen MS. 1999. Purification and assays for high mobility group HMG-I(Y) protein function. Meth. Enzymol. 304: 155-188.
333. Reeves R, Edberg DD, Li Y. 2001. Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells. Mol. Cell Biol. 21: 575-594.
334. Reichlin M. 1972. Localizing antigenic determinants in human haemoglobin with mutants: molecular correlations of immunological tolerance. J. Mol. Biol. 64: 485-496.
335. Ren D, Navarro B, Perez G, Jackson AC, Hsu S, Shi Q, Tilly JL, Clapham DE. 2001. A sperm ion channel required for sperm motility and male fertility. Nature 413: 603-609.
336. Rhodes G. 1993. Crystallography Made Crystal Clear: a Guide for Users of Macromolecular Models. Academic Press: San Diego, CA.
337. Ringe D, Petsko GA. 1986. Study of protein dynamics by X-ray diffraction. Meth. Enzymol. 131: 389-433.
338. Rini JM, Schulze-Gahmen U, Wilson IA. 1992. Structural evidence for induced fit as a mechanism for antibody-antigen recognition. Science 255: 959-965.
339. Robey WG, Safai B, Oroszlan S, Arthur LO, Gonda MA, Gallo RC, Fischinger PJ. 1985. Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients. Science 228: 593-595.
340. Robey WG, Arthur LO, Matthews TJ, Langlois A, Copeland TD, Lerche NW, Oroszlan S, Bolognesi DP, Gilden RV, Fischinger PJ. 1986. Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody. Proc. Natl Acad. Sci. USA 83: 7023-7707.
341. Romero P, Obradovic Z, Dunker AK. 1997a. Sequence data analysis for long disordered regions prediction in the calcineurin family. Genome Informat. 8: 110-124.
342. Romero P, Obradovic Z, Kissinger C, Villafranca JE, Dunker AK. 1997b. Identifying disordered regions in proteins from amino acid sequence. Proc. Int. Conf. Neural Networks 1: 90-95.
343. Romero P, Obradovic Z, Kissinger CR, Villafranca JE, Garner E, Guilliot S, Dunker AK. 1998. Thousands of proteins likely to have long disordered regions. Pac. Symp. Biocomput.: 437-448.
344. Romero P, Obradovic Z, Dunker AK. 1999. Folding minimal sequences: the lower bound for sequence complexity of globular proteins. FEBS Lett. 462: 363-367.
345. Romero P, Obradovic Z, Li X, Garner EC, Brown CJ, Dunker AK. 2001. Sequence complexity of disordered protein. Proteins 42: 38-48.
346. Romesberg FE, Spiller B, Schultz PG, Stevens RC. 1998. Immunological origins of binding and catalysis in a Diels-Alderase antibody. Science 279: 1929-1933.
347. Rosenfeld R, Vajda S, DeLisi C. 1995. Flexible docking and design. A. Rev. Biophys. Biomol. Struct. 24: 677-700.
348. Ross SE, Erickson RL, Hemati N, MacDougald OA. 1999. Glycogen synthase kinase 3 is an insulin-regulated C/EBPalpha kinase. Mol. Cell Biol. 19: 8433-8441.
349. Ross W, Gosink KK, Salomon J, Igarashi K, Zou C, Ishihama A, Severinov K, Gourse RL. 1993. A third recognition element in bacterial promoters: DNA binding by the alpha subunit of RNA polymerase. Science 262: 1407-1413.
350. Rusche JR, Javaherian K, McDanal C, Petro J, Lynn DL, Grimaila R, Langlois A, Gallo RC, Arthur LO, Fischinger PJ, Bolognesi DP, Putney SD, Matthews TJ. 1988. Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc. Natl Acad. Sci. USA 85: 3198-3202.
351. Rustandi RR, Baldisseri DM, Weber DJ. 2000. Structure of the negative regulatory domain of p53 bound to S100B(beta-beta). Nat. Struct. Biol. 7: 570-574.
352. Ryden C, Yacoub AI, Maxe I, Heinegard D, Oldberg A, Franzen A, Ljungh A, Rubin K. 1989. Specific binding of bone sialoprotein to Staphylococcus aureus isolated from patients with osteomyelitis. Eur. J. Biochem. 184: 331-336.
353. Schechter B, Conway-Jacobs A, Sela M. 1971. Conformational changes in a synthetic antigen induced by specific antibodies. Eur. J. Biochem. 20: 321-324.
354. Schulz GE. 1979. Nucleotide binding proteins. In Molecular Mechanism of Biological Recognition, Balaban M (ed.). Elsevier/North-Holland Biomedical Press: New York; 79-94.
355. Schwarzinger S, Kroon GJ, Foss TR, Chung J, Wright PE, Dyson HJ. 2001. Sequence-dependent correction of random coil NMR chemical shifts. J. Am. Chem. Soc. 123: 2970-2978.
356. Schweers O, Schonbrunn-Hanebeck E, Marx A, Mandelkow E. 1994. Structural studies of tau protein and Alzheimer paired helical filaments show no evidence for beta-structure. J. Biol. Chem. 269: 24290-24297.
357. Scully R. 2000. Role of BRCA gene dysfunction in breast and ovarian cancer predisposition. Breast Cancer Res. 2: 324-330.
358. Scully R, Livingston DM. 2000. In search of the tumour-suppressor functions of BRCA1 and BRCA2. Nature 408: 429-432.
359. Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM. 1997. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88: 265-275.
360. Seeling JM, Miller JR, Gil R, Moon RT, White R, Virshup DM. 1999. Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A. Science 283: 2089-2091.
361. Shamoo Y, Krueger U, Rice LM, Williams KR, Steitz TA. 1997. Crystal structure of the two RNA binding domains of human hnRNP A1 at 1.75 A resolution. Nat. Struct. Biol. 4: 215-222.
362. Sigler PB. 1988. Transcriptional activation. Acid blobs and negative noodles. Nature 333: 210-212.
363. Signas C, Raucci G, Jonsson K, Lindgren PE, Anantharamaiah GM, Hook M, Lindberg M. 1989. Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically active peptides. Proc. Natl Acad. Sci. USA 86: 699-703.
364. Slijper M, Bonvin AM, Boelens R, Kaptein R. 1996. Refined structure of lac repressor headpiece (1-56) determined by relaxation matrix calculations from 2D and 3D NOE data: change of tertiary structure upon binding to the lac operator. J. Mol. Biol. 259: 761-773.
365. Slijper M, Boelens R, Davis AL, Konings RN, van der Marel GA, van Boom JH, Kaptein R. 1997. Backbone and side chain dynamics of lac repressor headpiece (1-56) and its complex with DNA. Biochemistry 36: 249-254.
366. Smulders R, Carver JA, Lindner RA, van Boekel MA, Bloemendal H, de Jong WW. 1996. Immobilization of the C-terminal extension of bovine alphaA-crystallin reduces chaperone-like activity. J. Biol. Chem. 271: 29060-29066.
367. Smyth E, Syme CD, Blanch EW, Hecht L, Vasak M, Barron LD. 2001. Solution structure of native proteins with irregular folds from Raman optical activity. Biopolymers 58: 138-151.
368. Sobue K, Sellers JR. 1991. Caldesmon, a novel regulatory protein in smooth muscle and nonmuscle actomyosin systems. J. Biol. Chem. 266: 12115-12118.
369. Speziale P, Joh D, Visai L, Bozzini S, House-Pompeo K, Lindberg M, Hook M. 1996. A monoclonal antibody enhances ligand binding of fibronectin MSCRAMM (adhesin) from Streptococcus dysgalactiae. J. Biol. Chem. 271: 1371-1378.
370. Spolar RS, Record MT Jr. 1994. Coupling of local folding to site-specific binding of proteins to DNA. Science 263: 777-784.
371. Spronk CA, Slijper M, van Boom JH, Kaptein R, Boelens R. 1996. Formation of the hinge helix in the lac repressor is induced upon binding to the lac operator. Nat. Struct. Biol. 3: 916-919.
372. Stanfield R, Cabezas E, Satterthwait A, Stura E, Profy A, Wilson I. 1999. Dual conformations for the HIV-1 gp120 V3 loop in complexes with different neutralizing fabs. Struct. Fold. Des. 7: 131-142.
373. Steege DA. 2000. Emerging features of mRNA decay in bacteria. Rna 6: 1079-1090.
374. Stoldt M, Wohnert J, Ohlenschlager O, Gorlach M, Brown LR. 1999. The NMR structure of the 5S rRNA E-domain-protein L25 complex shows preformed and induced recognition. Embo J. 18: 6508-6521.
375. Switalski LM, Patti JM, Butcher W, Gristina AG, Speziale P, Hook M. 1993. A collagen receptor on Staphylococcus aureus strains isolated from patients with septic arthritis mediates adhesion to cartilage. Mol. Microbiol. 7: 99-107.
376. Tainer JA, Getzoff ED, Alexander H, Houghten RA, Olson AJ, Lerner RA, Hendrickson WA. 1984. The reactivity of antipeptide antibodies is a function of the atomic mobility of sites in a protein. Nature 312: 127-134.
377. Tainer JA, Getzoff ED, Paterson Y, Olson AJ, Lerner RA. 1985. The atomic mobility component of protein antigenicity. A. Rev. Immunol. 3: 501-535.
378. Talay SR, Valentin-Weigand P, Timmis KN, Chhatwal GS. 1994. Domain structure and conserved epitopes of Sfb protein, the fibronectin-binding adhesin of Streptococcus pyogenes. Mol. Microbiol. 13: 531-539.
379. Tallini G, Dal Cin P. 1999. HMGI(Y) and HMGI-C dysregulation: a common occurrence in human tumors. Adv. Anat. Pathol. 6: 237-246.
380. Taraseviciene L, Bjork GR, Uhlin BE. 1995. Evidence for an RNA binding region in the Escherichia coli processing endoribonuclease RNase E. J. Biol. Chem. 270: 26391-26398.
381. Terasaki M, Suzuki T, Hanada T, Watanabe K. 2004. Functional compatibility of elongation factors between mammalian mitochondrial and bacterial ribosomes: characterization of GTPase activity and translation elongation by hybrid ribosomes bearing heterologous L7/12 proteins. J. Mol. Biol. 336: 331-342.
382. Thomas GM, Frame S, Goedert M, Nathke I, Polakis P, Cohen P. 1999. A GSK3-binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and beta-catenin. FEBS Lett. 458: 247-251.
383. Thompson R, Esnouf R. 2004. Prediction of natively disordered regions in proteins using a bio-basis function neural network. In ntelligent Data Engineering and Automated Learning - IDEAL 2004: 5th International Conference, Exeter, UK. August 25-27, 2004. Proceedings, Yang ZR, Yin H, Everson R (eds). Springer: Berlin.
384. Tibbetts RS, Cortez D, Brumbaugh KM, Scully R, Livingston D, Elledge SJ, Abraham RT. 2000. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev. 14: 2989-3002.
385. Todd MJ, Lorimer GH, Thirumalai D. 1996. Chaperonin-facilitated protein folding: optimization of rate and yield by an iterative annealing mechanism. Proc. Natl Acad. Sci. USA 93: 4030-4035.
386. Tompa P. 2002. Intrinsically unstructured proteins. Trends Biochem. Sci. 27: 527-533.
387. Tompa P. 2003. Intrinsically unstructured proteins evolve by repeat expansion. Bioessays 25: 847-855.
388. Tompa P, Csermely P. 2004. The role of structural disorder in the function of RNA and protein chaperones. Faseb J. 18: 1169-1175.
389. Traut RR, Dey D, Bochkariov DE, Oleinikov AV, Jokhadze GG, Hamman B, Jameson D. 1995. Location and domain structure of Escherichia coli ribosomal protein L7/L12: site specific cysteine crosslinking and attachment of fluorescent probes. Biochem. Cell Biol. 73: 949-958.
390. Trkola A, Dragic T, Arthos J, Binley JM, Olson WC, Allaway GP, Cheng-Mayer C, Robinson J, Maddon PJ, Moore JP. 1996. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 384: 184-187.
391. Tucker MM, Robinson JB, Jr., Stellwagen E. 1981. The effect of proteolysis on the calmodulin activation of cyclic nucleotide phosphodiesterase. J. Biol. Chem. 256: 9051-9058.
392. Uetz P, Giot L, Cagney G, Mansfield TA, Judson RS, Knight JR, Lockshon D, Narayan V, Srinivasan M, Pochart P, Qureshi-Emili A, Li Y, Godwin B, Conover D, Kalbfleisch T, Vijayadamodar G, Yang M, Johnston M, Fields S, Rothberg JM. 2000. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 403: 623-627.
393. Uversky VN. 1999. A multiparametric approach to studies of self-organization of globular proteins. Biochemistry (Mosc.) 64: 250-266.
394. Uversky VN. 2002a. Natively unfolded proteins: a point where biology waits for physics. Protein Sci. 11: 739-756.
395. Uversky VN. 2002b. What does it mean to be natively unfolded? Eur. J. Biochem. 269: 2-12.
396. Uversky VN. 2003a. Protein folding revisited. A polypeptide chain at the folding-misfolding-nonfolding cross-roads: which way to go? Cell Mol. Life Sci. 60: 1852-1871.
397. Uversky VN. 2003b. A protein-chameleon: conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders. J. Biomol. Struct. Dyn. 21: 211-234.
398. Uversky VN, Ptitsyn OB. 1996. All-or-none solvent-induced transitions between native, molten globule and unfolded states in globular proteins. Fold. Des. 1: 117-122.
399. Uversky VN, Gillespie JR, Fink AL. 2000. Why are "natively unfolded" proteins unstructured under physiologic conditions? Proteins 41: 415-427.
400. Uversky VN, Permyakov SE, Zagranichny VE, Rodionov IL, Fink AL, Cherskaya AM, Wasserman LA, Permyakov EA. 2002. Effect of zinc and temperature on the conformation of the gamma subunit of retinal phosphodiesterase: a natively unfolded protein. J. Proteome Res. 1: 149-159.
401. Valcarcel J, Gebauer F. 1997. Post-transcriptional regulation: the dawn of PTB. Curr. Biol. 7: R705-708.
402. Valero ML, Camarero JA, Haack T, Mateu MG, Domingo E, Giralt E, Andreu D. 2000. Native-like cyclic peptide models of a viral antigenic site: finding a balance between rigidity and flexibility. J. Mol. Recognit. 13: 5-13.
403. Van Regenmortel MHV. 1995. Transcending the structuralist paradigm in immunology-affinity and biological activity rather than purely structural considerations should guide the design of synthetic peptide epitopes. Biomed. Pept. Proteins Nucl. Acids 1: 109-116.
404. Van Regenmortel MHV. 1999. Molecular dissection of protein antigens and prediction of epitopes. In Synthetic Peptides as Antigens, Van Regenmortel MHV, Mullar S (eds). Elsevier: Amsterdam; 1-78.
405. Varga JM, Kalchschmid G, Klein GF, Fritsch P. 1991a. Mechanism of allergic cross-reactions - I. Multispecific binding of ligands to a mouse monoclonal anti-DNP IgE antibody. Mol. Immunol. 28: 641-654.
406. Varga JM, Kalchschmid G, Klein GF, Fritsch P. 1991b. Mechanism of allergic cross-reactions - II. Cross-stimulation, by chemically unrelated ligands, of rat basophilic leukemia cells sensitized with an anti-DNP IgE antibody. Mol. Immunol. 28: 655-659.
407. Varshavsky A, Levinger L, Sundin O, Barsoum J, Ozkaynak E, Swerdlow P, Finley D. 1983. Cellular and SV40 chromatin: replication, segregation, ubiquitination, nuclease-hypersensitive sites, HMG-containing nucleosomes, and heterochromatin-specific protein. Cold Spring Harb. Symp. Quant. Biol. 47(Pt 1): 511-528.
408. Venkitaraman AR. 2001. Functions of BRCA1 and BRCA2 in the biological response to DNA damage. J. Cell. Sci. 114: 3591-3598.
409. Venyaminov SY, Gudkov AT, Gogia ZV, Tumanova LG. 1981. Absorption and Circular Dichroism Spectra of Individual Proteins from Escherichia coli Ribosomes. Scientific Center of Biological Research of the Academy of Sciences of the USSR: Pushchino.
410. Verdaguer N, Mateu MG, Andreu D, Giralt E, Domingo E, Fita I. 1995. Structure of the major antigenic loop of foot-and-mouth disease virus complexed with a neutralizing antibody: direct involvement of the Arg-Gly-Asp motif in the interaction. Embo J. 14: 1690-1696.
411. Verdaguer N, Mateu MG, Bravo J, Domingo E, Fita I. 1996. Induced pocket to accommodate the cell attachment Arg-Gly-Asp motif in a neutralizing antibody against foot-and-mouth-disease virus. J. Mol. Biol. 256: 364-376.
412. Verdaguer N, Sevilla N, Valero ML, Stuart D, Brocchi E, Andreu D, Giralt E, Domingo E, Mateu MG, Fita I. 1998. A similar pattern of interaction for different antibodies with a major antigenic site of foot-and-mouth disease virus: implications for intratypic antigenic variation. J. Virol. 72: 739-748.
413. Verdaguer N, Schoehn G, Ochoa WF, Fita I, Brookes S, King A, Domingo E, Mateu MG, Stuart D, Hewat EA. 1999. Flexibility of the major antigenic loop of foot-and-mouth disease virus bound to a Fab fragment of a neutralising antibody: structure and neutralisation. Virology 255: 260-268.
414. Veronese FD, DeVico AL, Copeland TD, Oroszlan S, Gallo RC, Sarngadharan MG. 1985. Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene. Science 229: 1402-1405.
415. Vihinen M, Torkkila E, Riikonen P. 1994. Accuracy of protein flexibility predictions. Proteins 19: 141-149.
416. Vorotnikov AV, Gusev NB. 1990. Interaction of smooth muscle caldesmon with phospholipids. FEBS Lett. 277: 134-136.
417. Vucetic S, Radivojac P, Dunker AK, Brown CJ, Obradovic Z. 2001. Methods for improving protein disorder prediction. Proceedings of International Joint INNS-IEEE Conference on Neural Networks 4: 2718-2823.
418. Vucetic S, Brown CJ, Dunker AK, Obradovic Z. 2003. Flavors of protein disorder. Proteins 52: 573-584.
419. Vucetic S, Obradovic Z, Vacic V, Radivojac P, Peng K, Iakoucheva LM, Cortese MS, Lawson JD, Brown CJ, Sikes JG, Newton CD, Dunker AK. 2005. DisProt: a database of protein disorder. Bioinformatics 21: 137-140.
420. Wachi M, Umitsuki G, Shimizu M, Takada A, Nagai K. 1999. Escherichia coli cafA gene encodes a novel RNase, designated as RNase G, involved in processing of the 5′ end of 16S rRNA. Biochem. Biophys. Res. Commun. 259: 483-488.
421. Wang Q, Zhang H, Kajino K, Greene MI. 1998. BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells. Oncogene 17: 1939-1948.
422. Ward JJ, McGuffin LJ, Bryson K, Buxton BF, Jones DT. 2004a. The DISOPRED server for the prediction of protein disorder. Bioinformatics 20: 2138-2139.
423. Ward JJ, Sodhi JS, McGuffin LJ, Buxton BF, Jones DT. 2004b. Prediction and function alanalysis of native disorder in proteins from the three kingdoms of life. J. Mol. Biol. 337: 635-645.
424. Watts DJ, Strogatz SH. 1998. Collective dynamics of 'small-world' networks. Nature 393: 440-442.
425. Weathers EA, Paulaitis ME, Woolf TB, Hoh JH. 2004. Reduced amino acid alphabet is sufficient to accurately recognize intrinsically disordered protein. FEBS Lett. 576: 348-352.
426. Weber JD, Kuo ML, Bothner B, DiGiammarino EL, Kriwacki RW, Roussel MF, Sherr CJ. 2000. Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex. Mol. Cell. Biol. 20: 2517-2528.
427. Wedemayer GJ, Patten PA, Wang LH, Schultz PG, Stevens RC. 1997. Structural insights into the evolution of an antibody combining site. Science 276: 1665-1669.
428. Weikl T, Abelmann K, Buchner J. 1999. An unstructured C-terminal region of the Hsp90 co-chaperone p23 is important for its chaperone function. J. Mol. Biol. 293: 685-691.
429. Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT Jr. 1996. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry 35: 13709-13715.
430. Weiss MA, Ellenberger T, Wobbe CR, Lee JP, Harrison SC, Struhl K. 1990. Folding transition in the DNA-binding domain of GCN4 on specific binding to DNA. Nature 347: 575-578.
431. Weliky DP, Bennett AE, Zvi A, Anglister J, Steinbach PJ, Tycko R. 1999. Solid-state NMR evidence for an antibody-dependent conformation of the V3 loop of HIV-1 gp120. Nat. Struct. Biol. 6: 141-145.
432. Wen L, Huang JK, Johnson BH, Reeck GR. 1989. A human placental cDNA clone that encodes nonhistone chromosomal protein HMG-1. Nucl. Acids Res. 17: 1197-1214.
433. Westhof E, Altschuh D, Moras D, Bloomer AC, Mondragon A, Klug A, Van Regenmortel MHV. 1984. Correlation between segmental mobility and the location of antigenic determinants in proteins. Nature 311: 123-126.
434. White-Scharf ME, Potts BJ, Smith LM, Sokolowski KA, Rusche JR, Silver S. 1993. Broadly neutralizing monoclonal antibodies to the V3 region of HIV-1 can be elicited by peptide immunization. Virology 192: 197-206.
435. Williams RS, Green R, Glover JN. 2001. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1. Nat. Struct. Biol. 8: 838-842.
436. Williamson JR. 2000. Induced fit in RNA-protein recognition. Nat. Struct. Biol. 7: 834-837.
437. Wilson IA, Stanfield RL. 1994. Antibody-antigen interactions: new structures and new conformational changes. Curr. Opin. Struct. Biol. 4: 857-867.
438. Wilson IA, Haft DH, Getzoff ED, Tainer JA, Lerner RA, Brenner S. 1985. Identical short peptide sequences in unrelated proteins can have different conformations: a testing ground for theories of immune recognition. Proc. Natl Acad. Sci. USA 82: 5255-5259.
439. Wodarz A, Nusse R. 1998. Mechanisms of Wnt signaling in development. A. Rev. Cell Dev. Biol. 14: 59-88.
440. Woody RW. 1995. Circular dichroism. Meth. Enzymol. 246: 34-71.
441. Wootton JC. 1994. Non-globular domains in protein sequences: automated segmentation using complexity measures. Comput. Chem. 18: 269-285.
442. Wootton JC. 1997. Simple sequences of protein and DNA. In DNA and Protein Sequence Analysis: a Practical Approach, Bishop MJ, Rawlings CR (eds). Oxford University Press: Oxford; 169-183.
443. Wootton JC, Federhen S. 1993. Statistics of local complexity in amino acid sequences and sequence databases. Comput. Chem. 17: 149-163.
444. Wootton JC, Federhen S. 1996. Analysis of compositionally biased regions in sequence databases. Meth. Enzymol. 266: 554-571.
445. Wright PE, Dyson HJ. 1999. Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J. Mol. Biol. 293: 321-331.
446. Wu L, Gerard NP, Wyatt R, Choe H, Parolin C, Ruffing N, Borsetti A, Cardoso AA, Desjardin E, Newman W, Gerard C, Sodroski J. 1996. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384: 179-183.
447. Xu X, Weaver Z, Linke SP, Li C, Gotay J, Wang XW, Harris CC, Ried T, Deng CX. 1999. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell 3: 389-395.
448. Yen YM, Wong B, Johnson RC. 1998. Determinants of DNA binding and bending by the Saccharomyces cerevisiae high mobility group protein NHP6A that are important for its biological activities. Role of the unique N terminus and putative intercalating methionine. J. Biol. Chem. 273: 4424-4435.
449. Yost C, Farr GH, 3rd, Pierce SB, Ferkey DM, Chen MM, Kimelman D. 1998. GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis. Cell 93: 1031-1041.
450. Yusupov MM, Yusupova GZ, Baucom A, Lieberman K, Earnest TN, Cate JH, Noller HF. 2001. Crystal structure of the ribosome at 5.5 Å resolution. Science 292: 883-896.
451. Zagotta WN, Hoshi T, Aldrich RW. 1990. Restoration of inactivation in mutants of Shaker potassium channels by a peptide derived from ShB. Science 250: 568-571.
452. Zhang H, Somasundaram K, Peng Y, Tian H, Bi D, Weber BL, El-Deiry WS. 1998. BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene 16: 1713-1721.
453. Zhong Q, Chen CF, Li S, Chen Y, Wang CC, Xiao J, Chen PL, Sharp ZD, Lee WH. 1999. Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science 285: 747-750.